Anemia in the frail, elderly patient

Gabriele Röhrig, Gabriele Röhrig

Abstract

Anemia and frailty are two common findings in geriatric patients and have been shown to be associated with poor outcomes in this patient group. Recent studies have contributed to the growing evidence of a possible association with the age-related chronic inflammatory status known as "inflammaging". These findings do not only give a better insight into the pathogenesis of anemia in frailty, but also offer new treatment options. The present article focuses on this assumed association between anemia, frailty, and inflammaging and summarizes current management options for anemia in frail patients.

Keywords: anemia of chronic inflammation; eryptosis; frailty; inflammaging; reactive oxygen species.

Figures

Figure 1
Figure 1
Hypothetical association between frailty, ACI, and inflammaging.

References

    1. Artz AS. Anemia and the frail elderly. Semin Hematol. 2008;45(4):261–266.
    1. Chang SS, Weiss CO, Xue QL, Fried LP. Association between inflammatory-related disease burden and frailty: results from the Women’s Health and Aging Studies (WHAS) I and II. Arch Gerontol Geriatr. 2012;54(1):9–15.
    1. Leng S, Chaves P, Koenig K, Walston J. Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc. 2002;50(7):1268–1271.
    1. Baylis D, Bartlett DB, Patel HP, Roberts HC. Understanding how we age: insights into inflammaging. Longev Healthspan. 2013;2(1):8.
    1. Bloomer SA, Kregel KC, Brown KE. Heat stress stimulates hepcidin mRNA expression and C/EBPα protein expression in aged rodent liver. Arch Gerontol Geriatr. 2014;58(1):145–152.
    1. Shander A, Goodnough LT, Javidroozi M, et al. Iron deficiency anemia – bridging the knowledge and practice gap. Transfus Med Rev. 2014;28(3):156–166.
    1. Ince C, Mik EG. Microcirculatory and mitochondrial hypoxia in sepsis, shock and resuscitation. J Appl Physiol (1985) 2016;120(2):226–235.
    1. Alexa ID, Ilie AC, Moroşanu A, Voica A. Approaching frailty as the new geriatric syndrome. Rev Med Chir Soc Med Nat Iasi. 2013;117(3):680–685.
    1. Juárez-Cedillo T, Basurto-Acevedo L, Vega-García S, et al. Prevalence of anemia and its impact on the state of frailty in elderly people living in the community: SADEM study. Ann Hematol. 2014;93(12):2057–2062.
    1. Contreras M, Formiga F, Ferrer A, Chivite D, Padrós G, Montero A, Grupo Octabaix Profile and prognosis of patients over 85 years old with anemia living in the community. Octabaix Study. Rev Esp Geriatr Gerontol. 2015;50(5):211–215.
    1. Ng TP, Feng L, Nyunt MS, Larbi A, Yap KB. Frailty in older persons: multisystem risk factors and the Frailty Risk Index (FRI) J Am Med Dir Assoc. 2014;15(9):635–642.
    1. Hong CH, Falvey C, Harris TB, et al. Anemia and risk of dementia in older adults: findings from the Health ABC study. Neurology. 2013;81(6):528–533.
    1. Son SJ, Lee KS, Na DL, et al. Anemia associated with depressive symptoms in mild cognitive impairment with severe white matter hyperintensities. J Geriatr Psychiatry Neurol. 2011;24(3):161–167.
    1. Zakai NA, French B, Arnold AM, et al. Hemoglobin decline, function, and mortality in the elderly: the cardiovascular health study. Am J Hematol. 2013;88(1):5–9.
    1. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004;104(8):2263–2268.
    1. Paul SS, Abraham VJ. How healthy is our geriatric population? A community-based cross-sectional study. J Family Med Prim Care. 2015;4(2):221–225.
    1. Gaskell H, Derry S, Andrew Moore R, McQuay HJ. Prevalence of anaemia in older persons: systematic review. BMC Geriatr. 2008;14(8):1.
    1. Bach V, Schruckmayer G, Sam I, Kemmler G, Stauder R. Prevalence and possible causes of anemia in the elderly: a cross-sectional analysis of a large European university hospital cohort. Clin Interv Aging. 2014;22(9):1187–1196.
    1. Zilinski J, Zillmann R, Becker I, Benzing T, Schulz RJ, Röhrig G. Prevalence of anemia among elderly inpatients and its association with multidimensional loss of function. Ann Hematol. 2014;93(10):1645–1654.
    1. Röhrig G, Klossok W, Becker I, Benzing T, Schulz RJ. Prevalence of anemia among elderly patients in an emergency room setting. Eur Geriatr Med. 2014;5(1):3–7.
    1. Romero-Ruperto S, Pérez-Bocanegra MC, Duran-Taberna M, Toscano-Rivera A, Barbé-Gil Ortega J, San José-Laporte A. Anemia in elderly patients admitted to an acute geriatric ward. Rev Esp Geriatr Gerontol. 2015;50(3):122–125.
    1. Röhrig G, Rücker Y, Becker I, et al. Association of anemia with functional and nutritional status in the German multicenter study “GeriAnaemie2013”. Z Gerontol Geriatr. 2015;48(S1):S14–S02. German.
    1. Ahmed T, Haboubi N. Assessment and management of nutrition in older people and its importance to health. Clin Interv Aging. 2010;5:207–216.
    1. Chan LN, Mike LA. The science and practice of micronutrient supplementations in nutritional anemia: an evidence-based review. JPEN J Parenter Enteral Nutr. 2014;38(6):656–672.
    1. Makipour S, Kanapuru B, Ershler WB. Unexplained anemia in the elderly. Semin Hematol. 2008;45(4):250–254.
    1. World Health Organization Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1968;405:5–37.
    1. Zakai NA, Katz R, Hirsch C, et al. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med. 2005;165(19):2214–2220.
    1. Culleton BF, Manns BJ, Zhang J, Tonelli M, Klarenbach S, Hemmelgarn BR. Impact of anemia on hospitalization and mortality in older adults. Blood. 2006;107(10):3841–3846.
    1. Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood. 2006;107(5):1747–1750.
    1. Hunt KJ, Walsh BM, Voegeli D, Roberts HC. Inflammation in aging part 2: implications for the health of older people and recommendations for nursing practice. Biol Res Nurs. 2010;11(3):253–260.
    1. Theurl I, Schroll A, Sonnweber T, et al. Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats. Blood. 2011;118(18):4977–4984.
    1. Gomes AC, Gomes MS. Hematopoietic niches, erythropoiesis and anemia of chronic infection. Exp Hematol. 2015 Nov 22; Epub.
    1. Libregts SF, Gutiérrez L, de Bruin AM, et al. Chronic IFN-γ production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1/PU.1 axis. Blood. 2011;118(9):2578–2588.
    1. Felli N, Pedini F, Zeuner A, et al. Multiple members of the TNF super-family contribute to IFN-gamma-mediated inhibition of erythropoiesis. J Immunol. 2005;175(3):1464–1472.
    1. Franceschi C, Bonafè M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244–254.
    1. Vasto S, Candore G, Balistreri CR, et al. Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev. 2007;128(1):83–91.
    1. De Martinis M, Franceschi C, Monti D, Ginaldi L. Inflammation markers predicting frailty and mortality in the elderly. Exp Mol Pathol. 2006;80(3):219–227.
    1. Weiskopf D, Weinberger B, Grubeck-Loebenstein B. The aging of the immune system. Transpl Int. 2009;22(11):1041–1050.
    1. Fried LP, Tangen CM, Walston J, et al. Cardiovascular Health Study Collaborative Research Group Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–M156.
    1. Espinoza SE, Hazuda HP. Frailty prevalence and neighborhood residence in older Mexican Americans: the San Antonio longitudinal study of aging. J Am Geriatr Soc. 2015;63(1):106–111.
    1. Herr M, Robine JM, Aegerter P, Arvieu JJ, Ankri J. Contribution of socioeconomic position over life to frailty differences in old age: comparison of life-course models in a French sample of 2,350 old people. Ann Epidemiol. 2015;25(9):674–680.e1.
    1. de la Rica-Escuín M, González-Vaca J, Varela-Pérez R, et al. Frailty and mortality or incident disability in institutionalized older adults: the FINAL study. Maturitas. 2014;78(4):329–334.
    1. Runganga M, Peel NM, Hubbard RE. Multiple medication use in older patients in post-acute transitional care: a prospective cohort study. Clin Interv Aging. 2014;2(9):1453–1462.
    1. Ambler GK, Brooks DE, Al Zuhir N, et al. Effect of frailty on short-and mid-term outcomes in vascular surgical patients. Br J Surg. 2015;102(6):638–645.
    1. Kim SW, Han HS, Jung HW, et al. Multidimensional frailty score for the prediction of postoperative mortality risk. JAMA Surg. 2014;149(7):633–640.
    1. Silva JC, Moraes ZV, Silva C, et al. Understanding red blood cell parameters in the context of the frailty phenotype: interpretations of the FIBRA (Frailty in Brazilian Seniors) study. Arch Gerontol Geriatr. 2014;59(3):636–641.
    1. Macciò A, Madeddu C. Management of anemia of inflammation in the elderly. Anemia. 2012;2012:563251.
    1. Azzi A, Davies KJA, Kelly F. Free radical biology – terminology and critical thinking. FEBS Lett. 2004;558(1–3):3–6.
    1. Barnes PJ. Mechanisms of development of multimorbidity in the elderly. Eur Respir J. 2015;45(3):790–806.
    1. Okafor UH, Unuigbe EI. Cardio-renal-anemia syndrome: a report of three cases. Saudi J Kidney Dis Transpl. 2012;23(3):562–568.
    1. Wu IC, Lin CC, Hsiung CA. Emerging roles of frailty and inflammaging in risk assessment of age-related chronic diseases in older adults: the intersection between aging biology and personalized medicine. Biomedicine (Taipei) 2015;5(1):1.
    1. Martínez-Velilla N, Cambra-Contin K, García-Baztán A, Alonso-Renedo J, Herce PA, Ibáñez-Beroiz B. Change in red blood cell distribution width during the last years of life in geriatric patients. J Nutr Health Aging. 2015;19(5):590–594.
    1. Patel KV, Semba RD, Ferrucci L, et al. Red cell distribution width and mortality in older adults: a meta-analysis. J Gerontol A Biol Sci Med Sci. 2010;65(3):258–265.
    1. Hu D, Ren J, Wang G, Gu G, Li G, Liu S. Value of red cell distribution width for assessing disease activity in Crohn’s disease. Am J Med Sci. 2015;349(1):42–45.
    1. Lang E, Lang F. Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death. Biomed Res Int. 2015;2015:513–518.
    1. Pretorius E, Swanepoel AC, Buys AV, Vermeulen N, Duim W, Kell DB. Eryptosis as a marker of Parkinson’s disease. Aging (Albany NY) 2014;6(10):788–819.
    1. Lupescu A, Bissinger R, Goebel T, et al. Enhanced suicidal erythrocyte death contributing to anemia in the elderly. Cell Physiol Biochem. 2015;36(2):773–783.
    1. Judge S, Young MJ, Smith A, Hagen T, Leeuwenburgh C. Age-associated increases in oxidative stress and antioxidant enzyme activities in cardiac interfibrillar mitochondria: implications for the mitochondrial theory of aging. FASEB J. 2005;19(3):419–421.
    1. Ungvari Z, Orosz Z, Labinskyy N, et al. Increased mitochondrial H2O2 production promotes endothelial NF-κB activation in aged rat arteries. Am J Physiol Heart Circ Physiol. 2007;293(1):H37–H47.
    1. Metzgeroth G, Hastka J. Iron deficiency anemia and anemia of chronic disorders. Internist (Berl) 2015;56(9):978–988.
    1. Dahlerup JF, Eivindson M, Jacobsen BA, et al. Diagnosis and treatment of unexplained anemia with iron deficiency without overt bleeding. Dan Med J. 2015;62(4):C5072.
    1. Poetes J. Oral iron therapy in hemorrhagic, infectious and tumorous anemias. Hippokrates. 1954;25(20):651–652.
    1. Kulaksiz H, Theilig F, Bachmann S, et al. The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J Endocrinol. 2005;184(2):361–370.
    1. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101(7):2461–2463.
    1. Gangat N, Wolanskyj AP. Anemia of chronic disease. Semin Hematol. 2013;50(3):232–238.
    1. Bach M, Geisel T, Martin J, et al. Efficacy and safety of intravenous ferric carboxymaltose in geriatric inpatients at a German tertiary university teaching hospital: a retrospective observational cohort study of clinical practice. Anemia. 2015;2015:647930.
    1. Röhrig G, Steinmetz T, Stein J, et al. Efficacy and tolerability of ferric carboxymaltose in geriatric patients with anemia. Data from three non-interventional studies. MMW Fortschr Med. 2014;156(Suppl 2):48–53.
    1. Reed J, Charytan C, Yee J. The safety of intravenous iron sucrose use in the elderly patient. Consult Pharm. 2007;22(3):230–238.
    1. Hastka J, Heimpel H, Metzgeroth G. Eisenmangel und Eisenmangelanämie [Onkopedia guideline] [Accessed October 23, 2015]. Available from: . German.
    1. Tay HS, Soiza RL. Systematic review and meta-analysis: what is the evidence for oral iron supplementation in treating anaemia in elderly people? Drugs Aging. 2015;32(2):149–158.
    1. Silay K, Akinci S, Yalcin A, et al. The status of iron absorption in older patients with iron deficiency anemia. Eur Rev Med Pharmacol Sci. 2015;19(17):3142–3145.
    1. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69(Suppl 1):S4–S9.
    1. German Medical Association . (Bundesärztekammer): Guidelines of the German Medical Association for Therapy with Blood Components and Plasma Derivatives. 4th revised edition. German Medical Publishers (Deutscher Ärzte Verlag); 2014. pp. 10–19. Chapters 1. German.
    1. Gregersen M, Borris LC, Damsgaard EM. Blood transfusion and overall quality of life after hip fracture in frail elderly patients – the transfusion requirements in frail elderly randomized controlled trial. J Am Med Dir Assoc. 2015;16(9):762–766.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться